Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $99.9300 (2.04%) ($96.8300 - $99.9300) on Tue. Mar. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.63% (three month average) | RSI | 30 | Latest Price | $99.9300(2.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -5.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(61%) IWO(61%) IWM(60%) IWC(57%) IWN(57%) | Factors Impacting LGND price | LGND will decline at least -1.815% in a week (0% probabilities). VIXM(-27%) UUP(-22%) VXX(-17%) EDOC(-8%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.815% (StdDev 3.63%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $83.35(-16.59%) | Resistance Level | $107.74 | 5 Day Moving Average | $99.57(0.36%) | 10 Day Moving Average | $99.69(0.24%) | 20 Day Moving Average | $107.74(-7.25%) | To recent high | -38.7% | To recent low | 4.8% | Market Cap | $1.606b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |